Objective <p>To assess whether Family Integrated Care (FICare) model including Family-Centered Rounds (FCR) reduces parental stress in neonatal wards.</p> Study Design <p>A multicenter, stepped-wedge cluster-randomized trial was conducted in ten level II neonatal wards in The Netherlands (March 2022–December 2023). Participants included parents of 613 infants hospitalized for ≥7 days. The primary outcome was parental stress at discharge (PSS:NICU scale). Secondary outcomes included parental participation, anxiety, trauma, depression, shared decision-making, and bonding.</p> Results <p>FICare significantly increased parental participation (<i>P</i> &lt; 0.001) but did not reduce overall stress at discharge (FICare 61.2 vs. SNC 62.5, <i>P</i> = 0.21). Trauma symptoms in partners decreased (<i>P</i> = 0.03), and parents of transferred infants showed reduced stress (P = 0.01).</p> Conclusion <p>While FICare improved parental involvement, overall stress reduction was limited, with benefits seen in reduced trauma symptoms in partners and a reduction of stress in parents of transferred infants.</p> Trial registration <p>The trial has been registered at Clinical Trials.gov under registration number NCT05343403.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Family integrated care reduces stress in transferred parents of preterm infants, but not across all families: a stepped-wedge cluster-randomized trial

  • M. T. Alferink,
  • H. Hoeben,
  • N. H. Jonkman,
  • J. B. van Goudoever,
  • A. A. M. W. van Kempen,
  • N. R. van Veenendaal,
  • S. R. D. van der Schoor,
  • M. J. M. van Brakel,
  • R. H. T. van Beek,
  • C. R. L. Boot,
  • G. Damhuis,
  • A. M. de Grauw,
  • F. de Groof,
  • L. H. Hendrikx,
  • A. K. E. Hoffmann-Haringsma,
  • A. G. Kaspers,
  • N. H. M. Labrie,
  • E. Lopriore,
  • C. A. M. Lutterman,
  • S. A. Obermann-Borst,
  • M. Rijpert,
  • M. J. Vermeulen,
  • F. Visser

摘要

Objective

To assess whether Family Integrated Care (FICare) model including Family-Centered Rounds (FCR) reduces parental stress in neonatal wards.

Study Design

A multicenter, stepped-wedge cluster-randomized trial was conducted in ten level II neonatal wards in The Netherlands (March 2022–December 2023). Participants included parents of 613 infants hospitalized for ≥7 days. The primary outcome was parental stress at discharge (PSS:NICU scale). Secondary outcomes included parental participation, anxiety, trauma, depression, shared decision-making, and bonding.

Results

FICare significantly increased parental participation (P < 0.001) but did not reduce overall stress at discharge (FICare 61.2 vs. SNC 62.5, P = 0.21). Trauma symptoms in partners decreased (P = 0.03), and parents of transferred infants showed reduced stress (P = 0.01).

Conclusion

While FICare improved parental involvement, overall stress reduction was limited, with benefits seen in reduced trauma symptoms in partners and a reduction of stress in parents of transferred infants.

Trial registration

The trial has been registered at Clinical Trials.gov under registration number NCT05343403.